Enterotoxigenic Escherichia coli elicits immune responses to multiple surface proteins.
Enterotoxigenic Escherichia coli (ETEC) causes considerable morbidity and mortality due to diarrheal illness in developing countries, particularly in young children. Despite the global importance of these heterogeneous pathogens, a broadly protective vaccine is not yet available. While much is known regarding the immunology of well-characterized virulence proteins, in particular the heat-labile toxin (LT) and colonization factors (CFs), to date, evaluation of the immune response to other antigens has been limited. However, the availability of genomic DNA sequences for ETEC strains coupled with proteomics technology affords opportunities to examine novel uncharacterized antigens that might also serve as targets for vaccine development. Analysis of whole or fractionated bacterial proteomes with convalescent-phase sera can potentially accelerate identification of secreted or surface-expressed targets that are recognized during the course of infection. Here we report results of an immunoproteomics approach to antigen discovery with ETEC strain H10407. Immunoblotting of proteins separated by two-dimensional electrophoresis (2DE) with sera from mice infected with strain H10407 or with convalescent human sera obtained following natural ETEC infections demonstrated multiple immunoreactive molecules in culture supernatant, outer membrane, and outer membrane vesicle preparations, suggesting that many antigens are recognized during the course of infection. Proteins identified by this approach included established virulence determinants, more recently identified putative virulence factors, as well as novel secreted and outer membrane proteins. Together, these studies suggest that existing and emerging proteomics technologies can provide a useful complement to ongoing approaches to ETEC vaccine development.
Roy
Koushik
K
Department of Medicine, University of Tennessee Health Sciences Center, Memphis, Tennessee, USA.
Bartels
Scott
S
Qadri
Firdausi
F
Fleckenstein
James M
JM
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology* / Q000302:isolation & purification; D004591:Electrophoresis, Polyacrylamide Gel; D054307:Enterotoxigenic Escherichia coli / Q000276:immunology*; D004927:Escherichia coli Infections / Q000276:immunology* / Q000382:microbiology; D005434:Flow Cytometry; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D056724:Immunity, Humoral / Q000276:immunology; D015151:Immunoblotting; D007525:Isoelectric Focusing; D051379:Mice
D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins
Clin Microbiol Rev. 1997 Oct;10(4):569-84
9336662
J Bacteriol. 2007 Apr;189(8):3228-36
17293413
Electrophoresis. 1999 Dec;20(18):3551-67
10612281
Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):547-52
15647345
J Bacteriol. 2008 Oct;190(20):6881-93
18676672
Nature. 2001 Apr 26;410(6832):1099-103
11323673
Infect Immun. 2006 Apr;74(4):2245-58
16552055
J Bacteriol. 1970 Nov;104(2):882-9
4923077
Nat Protoc. 2009;4(7):1083-92
19707189
Infect Immun. 2006 Feb;74(2):869-75
16428729
Infect Immun. 1994 Aug;62(8):3463-71
8039917
Infect Immun. 1977 Nov;18(2):348-51
336543
Infect Immun. 2007 Aug;75(8):3941-9
17517861
Expert Rev Vaccines. 2009 Dec;8(12):1653-5
19943760
Expert Rev Vaccines. 2008 Aug;7(6):795-804
18665777
Nature. 2009 Jan 29;457(7229):594-8
19060885
Clin Microbiol Rev. 2005 Jul;18(3):465-83
16020685
J Infect Dis. 1977 Aug;136 Suppl:S118-23
330772
Proc Natl Acad Sci U S A. 2009 Jun 30;106(26):10793-8
19515814
FEMS Microbiol Immunol. 1988 Dec;1(3):117-25
3078739
Infect Immun. 2005 May;73(5):3137-46
15845522
J Clin Microbiol. 1980 Jan;11(1):35-40
6986402
Cell Microbiol. 2006 Sep;8(9):1516-27
16922869
Lancet. 2003 Jul 26;362(9380):286-91
12892959
Mol Microbiol. 1999 Nov;34(4):767-79
10564516
Infect Immun. 1999 Dec;67(12):6234-41
10569732
Trends Microbiol. 1996 Nov;4(11):444-52
8950814
Mol Cell Proteomics. 2008 Mar;7(3):473-85
17982123
Infect Immun. 2007 Jan;75(1):278-89
17074858
Proteomics. 2002 May;2(5):580-90
11987132
Vaccine. 2007 Mar 30;25(14):2545-66
17224212
J Bacteriol. 2005 Sep;187(18):6509-16
16159784
BMC Microbiol. 2009 Oct 16;9:220
19835618
BMC Genomics. 2008 Feb 08;9:75
18261238
Infect Immun. 1977 Jun;16(3):781-8
330395
Infect Immun. 1975 Sep;12(3):656-67
1100526
Infect Immun. 1999 Aug;67(8):4084-91
10417177
Infect Immun. 2007 Jan;75(1):252-9
17074855
J Clin Microbiol. 2009 Jan;47(1):189-97
18971368
Proteomics. 2002 Oct;2(10):1435-44
12422360
J Bacteriol. 2007 May;189(9):3532-46
17351047
J Infect Dis. 1995 Apr;171(4):1045-9
7706787
Curr Opin Gastroenterol. 2005 Jan;21(1):15-9
15687879
J Clin Microbiol. 1999 Sep;37(9):2974-8
10449484
J Biol Chem. 1972 Jul 10;247(13):4160-4
4113817
J Infect Dis. 2005 Feb 15;191(4):562-70
15655780
N Engl J Med. 1988 May 12;318(19):1240-3
3283555
Infect Immun. 1996 Jun;64(6):2256-65
8675335
Infect Immun. 1994 Dec;62(12):5624-31
7960144
Infect Immun. 1980 Aug;29(2):704-13
7011982
J Bacteriol. 2007 Jul;189(14):5060-7
17496090
Clin Chem. 1980 Aug;26(9):1255-60
6772340
Infect Immun. 2006 Jul;74(7):3864-73
16790758
Infect Immun. 1979 Mar;23(3):729-36
378834
Vaccine. 2009 Jul 23;27(34):4601-8
19523914
PLoS Pathog. 2009 Sep;5(9):e1000586
19806177
Infect Immun. 2007 Jun;75(6):2841-52
17353282
J Biol Chem. 2000 Apr 28;275(17):12489-96
10777535
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17020-4
12471157
Microbes Infect. 2010 Feb;12(2):89-98
19883790
Infect Immun. 2004 Mar;72(3):1786-94
14977988
Infect Immun. 2008 May;76(5):2106-12
18285493
Infect Immun. 1978 Aug;21(2):638-47
80383
Infect Immun. 2007 Aug;75(8):3961-8
17548483